Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitor
go back to main search page
Accession:CHEBI:77102 term browser browse the term
Definition:An EC 1.3.* (oxidoreductase acting on donor CH-CH group) inhibitor that interferes with the action of any such enzyme using a quinone or related compound as acceptor (EC 1.3.5.*).
Synonyms:related_synonym: EC 1.3.5.* inhibitor;   EC 1.3.5.* inhibitors;   inhibitor of oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor;   inhibitor of oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor (EC 1.3.5.*);   inhibitors of oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor;   inhibitors of oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor (EC 1.3.5.*);   oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor (EC 1.3.5.*) inhibitors



show annotations for term's descendants           Sort by:
 
3-nitropropanoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase (Cartwright blood group) multiple interactions
increases activity
ISO thymoquinone inhibits the reaction [3-nitropropionic acid results in increased activity of ACHE protein]; trandolapril inhibits the reaction [3-nitropropionic acid results in increased activity of ACHE protein] CTD PMID:25445565 PMID:27206696 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
JBrowse link
G AKT1 AKT serine/threonine kinase 1 decreases phosphorylation
multiple interactions
ISO 3-nitropropionic acid results in decreased phosphorylation of AKT1 protein
topiramate inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of AKT1 protein]
CTD PMID:29753867 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G BAD BCL2 associated agonist of cell death multiple interactions
increases expression
ISO naringin inhibits the reaction [3-nitropropionic acid results in increased expression of BAD mRNA] CTD PMID:21945202 NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
JBrowse link
G BAX BCL2 associated X, apoptosis regulator affects localization
increases expression
multiple interactions
ISO 3-nitropropionic acid affects the localization of BAX protein
3-nitropropionic acid results in increased expression of BAX mRNA
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein; Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in increased expression of BAX mRNA]; naringin inhibits the reaction [3-nitropropionic acid results in increased expression of BAX mRNA]; ursodoxicoltaurine inhibits the reaction [3-nitropropionic acid affects the localization of BAX protein]
CTD PMID:11080188 PMID:15571979 PMID:21827809 PMID:21945202 NCBI chr19:48,954,825...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator multiple interactions
decreases expression
ISO [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein; BCL2 protein promotes the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]; naringin inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2 mRNA] CTD PMID:15571979 PMID:19428112 PMID:21945202 NCBI chr18:63,123,346...63,320,280
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2L1 BCL2 like 1 decreases expression
multiple interactions
ISO 3-nitropropionic acid results in decreased expression of BCL2L1 mRNA
Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2L1 mRNA]
CTD PMID:21827809 NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
JBrowse link
G BDNF brain derived neurotrophic factor decreases response to substance
decreases expression
multiple interactions
ISO BDNF protein results in decreased susceptibility to 3-nitropropionic acid
3-nitropropionic acid results in decreased expression of BDNF protein
BCL2 protein promotes the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]; Dinitrochlorobenzene inhibits the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]; KT 5823 inhibits the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]; topiramate inhibits the reaction [3-nitropropionic acid results in decreased expression of BDNF protein]
CTD PMID:19428112 PMID:29753867 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
JBrowse link
G CASP2 caspase 2 increases activity ISO 3-nitropropionic acid results in increased activity of CASP2 protein CTD PMID:15571979 NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
JBrowse link
G CASP3 caspase 3 increases activity
increases cleavage
multiple interactions
ISO 3-nitropropionic acid results in increased activity of CASP3 protein
3-nitropropionic acid results in increased cleavage of CASP3 protein
naringin inhibits the reaction [3-nitropropionic acid results in increased cleavage of CASP3 protein]; Tacrolimus inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]; topiramate inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]
CTD PMID:15571979 PMID:21945202 PMID:29753867 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CASP8 caspase 8 increases activity ISO 3-nitropropionic acid results in increased activity of CASP8 protein CTD PMID:15571979 NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,287,711
JBrowse link
G CASP9 caspase 9 increases activity ISO 3-nitropropionic acid results in increased activity of CASP9 protein CTD PMID:15571979 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CAT catalase multiple interactions
decreases activity
decreases expression
ISO 3-nitropropionic acid affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of CAT protein]]; 3-nitropropionic acid affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of CAT protein]; 3-nitropropionic acid affects the reaction [Ethanol affects the expression of CAT protein]; Cyclosporine inhibits the reaction [3-nitropropionic acid results in decreased expression of CAT protein]; naringin inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; Nitric Oxide promotes the reaction [Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]]; Nitric Oxide promotes the reaction [Venlafaxine Hydrochloride inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]]; Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; thymoquinone analog inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; thymoquinone inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; trandolapril inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]; Venlafaxine Hydrochloride inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein] CTD PMID:20305041 PMID:20448265 PMID:21945202 PMID:25445565 PMID:27206696 More... NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CCND1 cyclin D1 increases expression ISO 3-nitropropionic acid results in increased expression of CCND1 protein CTD PMID:21827787 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CDK4 cyclin dependent kinase 4 increases expression ISO 3-nitropropionic acid results in increased expression of CDK4 protein CTD PMID:21827787 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
JBrowse link
G CNR1 cannabinoid receptor 1 affects expression ISO 3-nitropropionic acid affects the expression of CNR1 mRNA CTD PMID:15640759 NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
JBrowse link
G COX4I1 cytochrome c oxidase subunit 4I1 decreases expression ISO 3-nitropropionic acid results in decreased expression of COX4I1 mRNA CTD PMID:19306371 NCBI chr16:85,799,695...85,807,068
Ensembl chr16:85,798,633...85,807,068
JBrowse link
G COX4I2 cytochrome c oxidase subunit 4I2 increases response to substance
increases expression
ISO COX4I2 mRNA results in increased susceptibility to 3-nitropropionic acid
3-nitropropionic acid results in increased expression of COX4I2 mRNA
CTD PMID:19306371 NCBI chr20:31,637,856...31,645,009
Ensembl chr20:31,637,912...31,645,006
JBrowse link
G CREB1 cAMP responsive element binding protein 1 multiple interactions
decreases phosphorylation
ISO topiramate inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of CREB1 protein] CTD PMID:29753867 NCBI chr 2:207,529,943...207,605,988
Ensembl chr 2:207,529,737...207,605,988
JBrowse link
G ENO2 enolase 2 decreases expression
multiple interactions
ISO 3-nitropropionic acid results in decreased expression of ENO2 mRNA
Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of ENO2 mRNA]
CTD PMID:17672854 NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
JBrowse link
G GAPDH glyceraldehyde-3-phosphate dehydrogenase multiple interactions
increases expression
ISO Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in increased expression of GAPDH mRNA] CTD PMID:21827809 NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit multiple interactions ISO [naringin co-treated with 3-nitropropionic acid] results in increased expression of GCLC mRNA CTD PMID:22871521 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
JBrowse link
G GRIA2 glutamate ionotropic receptor AMPA type subunit 2 multiple interactions
decreases expression
ISO topiramate inhibits the reaction [3-nitropropionic acid results in decreased expression of GRIA2 mRNA] CTD PMID:29753867 NCBI chr 4:157,220,120...157,370,583
Ensembl chr 4:157,204,182...157,366,075
JBrowse link
G GSK3B glycogen synthase kinase 3 beta decreases phosphorylation
multiple interactions
ISO 3-nitropropionic acid results in decreased phosphorylation of GSK3B protein
topiramate inhibits the reaction [3-nitropropionic acid results in decreased phosphorylation of GSK3B protein]
CTD PMID:29753867 NCBI chr 3:119,821,321...120,095,823
Ensembl chr 3:119,821,321...120,094,994
JBrowse link
G GSR glutathione-disulfide reductase multiple interactions
decreases activity
ISO naringin inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein]; thymoquinone analog inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein]; thymoquinone inhibits the reaction [3-nitropropionic acid results in decreased activity of GSR protein] CTD PMID:21945202 PMID:27206696 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G GSTP1 glutathione S-transferase pi 1 multiple interactions ISO [naringin co-treated with 3-nitropropionic acid] results in increased expression of GSTP1 mRNA CTD PMID:22871521 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions ISO [naringin co-treated with 3-nitropropionic acid] results in increased expression of HMOX1 mRNA CTD PMID:22871521 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G IL6 interleukin 6 multiple interactions
increases expression
ISO delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of IL6 mRNA] CTD PMID:28853159 NCBI chr 7:22,725,889...22,732,002
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G MAPT microtubule associated protein tau affects localization ISO 3-nitropropionic acid affects the localization of MAPT protein CTD PMID:17634376 NCBI chr17:45,894,538...46,028,334
Ensembl chr17:45,894,527...46,028,334
JBrowse link
G MKI67 marker of proliferation Ki-67 decreases expression ISO 3-nitropropionic acid results in decreased expression of MKI67 protein CTD PMID:21827787 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 multiple interactions ISO [naringin co-treated with 3-nitropropionic acid] affects the localization of NFE2L2 protein CTD PMID:22871521 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,227,595...177,392,697
JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 decreases response to substance ISO NFKB1 results in decreased susceptibility to 3-nitropropionic acid CTD PMID:11211235 NCBI chr 4:102,501,266...102,617,302
Ensembl chr 4:102,501,331...102,617,302
JBrowse link
G NOS2 nitric oxide synthase 2 increases expression
multiple interactions
ISO 3-nitropropionic acid results in increased expression of NOS2 mRNA
delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of NOS2 mRNA]; T 0070907 inhibits the reaction [delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of NOS2 mRNA]]
naringin inhibits the reaction [3-nitropropionic acid results in increased expression of NOS2 mRNA]
CTD PMID:22871521 PMID:28853159 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 multiple interactions ISO [naringin co-treated with 3-nitropropionic acid] results in increased expression of NQO1 mRNA CTD PMID:22871521 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G PENK proenkephalin decreases expression
multiple interactions
ISO 3-nitropropionic acid results in decreased expression of PENK mRNA
Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of PENK mRNA]
CTD PMID:17672854 NCBI chr 8:56,440,957...56,446,641
Ensembl chr 8:56,436,674...56,446,671
JBrowse link
G PICK1 protein interacting with PRKCA 1 increases expression
multiple interactions
ISO 3-nitropropionic acid results in increased expression of PICK1 protein
topiramate inhibits the reaction [3-nitropropionic acid results in increased expression of PICK1 protein]
CTD PMID:29753867 NCBI chr22:38,056,311...38,075,704
Ensembl chr22:38,056,311...38,075,701
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 increases expression
multiple interactions
ISO 3-nitropropionic acid results in increased expression of PTGS2 mRNA
naringin inhibits the reaction [3-nitropropionic acid results in increased expression of PTGS2 mRNA]
CTD PMID:22871521 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G RB1 RB transcriptional corepressor 1 decreases expression ISO 3-nitropropionic acid results in decreased expression of RB1 protein CTD PMID:21827787 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G SIRT1 sirtuin 1 decreases expression ISO 3-nitropropionic acid results in decreased expression of SIRT1 protein CTD PMID:18538940 NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions
decreases expression
ISO Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of SOD1 mRNA] CTD PMID:17672854 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SOD2 superoxide dismutase 2 decreases expression
multiple interactions
ISO 3-nitropropionic acid results in decreased expression of SOD2 mRNA
Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of SOD2 mRNA]
CTD PMID:17672854 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
JBrowse link
G TAC1 tachykinin precursor 1 decreases expression
multiple interactions
ISO 3-nitropropionic acid results in decreased expression of TAC1 mRNA
Cannabidiol inhibits the reaction [3-nitropropionic acid results in decreased expression of TAC1 mRNA]
CTD PMID:17672854 NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
JBrowse link
G TNF tumor necrosis factor increases expression
multiple interactions
ISO 3-nitropropionic acid results in increased expression of TNF mRNA
delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of TNF mRNA]; T 0070907 inhibits the reaction [delta(9)-tetrahydrocannabinolic acid inhibits the reaction [3-nitropropionic acid results in increased expression of TNF mRNA]]
naringin inhibits the reaction [3-nitropropionic acid results in increased expression of TNF mRNA]
CTD PMID:22871521 PMID:28853159 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
atovaquone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 increases activity EXP Atovaquone results in increased activity of CYP1A2 protein CTD PMID:11124226 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G DHODH dihydroorotate dehydrogenase (quinone) decreases activity
affects binding
ISO
EXP
Atovaquone results in decreased activity of DHODH protein
Atovaquone binds to Dhodh protein
CTD
RGD
PMID:10658902 PMID:15044733 RGD:2316233 NCBI chr16:72,008,744...72,027,659
Ensembl chr16:72,008,588...72,027,664
JBrowse link
G GSTP1 glutathione S-transferase pi 1 multiple interactions EXP Atovaquone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] CTD PMID:23769903 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
brequinar term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G DHODH dihydroorotate dehydrogenase (quinone) multiple interactions
decreases activity
ISO
EXP
brequinar inhibits the reaction [DHODH protein results in increased metabolism of 4,5-dihydroorotic acid]; brequinar inhibits the reaction [DHODH protein results in increased metabolism of Quinones]; brequinar inhibits the reaction [DHODH protein results in increased oxidation of 4,5-dihydroorotic acid]
brequinar results in decreased activity of DHODH protein
CTD PMID:9776318 PMID:9802339 PMID:10658902 NCBI chr16:72,008,744...72,027,659
Ensembl chr16:72,008,588...72,027,664
JBrowse link
carboxin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ANXA2 annexin A2 decreases expression EXP Carboxin results in decreased expression of ANXA2 mRNA CTD PMID:33512557 NCBI chr15:60,347,151...60,398,025
Ensembl chr15:60,347,134...60,402,883
JBrowse link
G BBC3 BCL2 binding component 3 decreases expression EXP Carboxin results in decreased expression of BBC3 mRNA CTD PMID:33512557 NCBI chr19:47,220,822...47,232,998
Ensembl chr19:47,220,822...47,232,766
JBrowse link
flutolanil term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 increases expression EXP flutolanil results in increased expression of CYP3A4 mRNA CTD PMID:17293382 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G ESR1 estrogen receptor 1 decreases expression
multiple interactions
EXP flutolanil results in decreased expression of ESR1 protein
flutolanil binds to and results in increased activity of ESR1 protein
CTD PMID:17904202 NCBI chr 6:151,654,148...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 multiple interactions ISO
EXP
flutolanil binds to and results in increased activity of NR1I2 protein CTD PMID:21115097 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
G PGR progesterone receptor increases expression EXP flutolanil results in increased expression of PGR mRNA CTD PMID:17904202 NCBI chr11:101,029,624...101,130,681
Ensembl chr11:101,029,624...101,129,813
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma increases activity EXP flutolanil results in increased activity of PPARG protein CTD PMID:20143881 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G TFF1 trefoil factor 1 increases expression EXP flutolanil results in increased expression of TFF1 mRNA CTD PMID:17904202 NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
JBrowse link
fluxapyroxad term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ANXA10 annexin A10 increases expression EXP fluxapyroxad results in increased expression of ANXA10 mRNA CTD PMID:32194361 NCBI chr 4:168,092,525...168,187,736
Ensembl chr 4:168,092,537...168,187,736
JBrowse link
G ARG1 arginase 1 decreases expression EXP fluxapyroxad results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions EXP [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP1A1 protein CTD PMID:29294346 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 multiple interactions
increases expression
EXP [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP2B6 protein
fluxapyroxad results in increased expression of CYP2B6 mRNA; fluxapyroxad results in increased expression of CYP2B6 protein
CTD PMID:29294346 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 decreases expression EXP fluxapyroxad results in decreased expression of CYP2C19 protein CTD PMID:32194361 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions
increases expression
EXP [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 mRNA; [fluxapyroxad co-treated with epoxiconazole] results in increased expression of CYP3A4 protein
fluxapyroxad results in increased expression of CYP3A4 mRNA
CTD PMID:29294346 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP fluxapyroxad results in decreased expression of CYP7A1 mRNA; fluxapyroxad results in decreased expression of CYP7A1 protein CTD PMID:32194361 NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 decreases expression EXP fluxapyroxad results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
JBrowse link
G S100P S100 calcium binding protein P increases expression EXP fluxapyroxad results in increased expression of S100P mRNA; fluxapyroxad results in increased expression of S100P protein CTD PMID:32194361 NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
JBrowse link
thifluzamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AARS1 alanyl-tRNA synthetase 1 increases expression EXP thifluzamide results in increased expression of AARS1 mRNA CTD PMID:33512557 NCBI chr16:70,252,295...70,289,509
Ensembl chr16:70,251,983...70,289,707
JBrowse link
G AKT1 AKT serine/threonine kinase 1 decreases expression EXP thifluzamide results in decreased expression of AKT1 mRNA CTD PMID:33512557 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G ALDH7A1 aldehyde dehydrogenase 7 family member A1 decreases expression EXP thifluzamide results in decreased expression of ALDH7A1 mRNA CTD PMID:33512557 NCBI chr 5:126,541,841...126,595,219
Ensembl chr 5:126,531,200...126,595,362
JBrowse link
G ALDOA aldolase, fructose-bisphosphate A increases expression EXP thifluzamide results in increased expression of ALDOA mRNA CTD PMID:33512557 NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
JBrowse link
G ANXA2 annexin A2 decreases expression EXP thifluzamide results in decreased expression of ANXA2 mRNA CTD PMID:33512557 NCBI chr15:60,347,151...60,398,025
Ensembl chr15:60,347,134...60,402,883
JBrowse link
G ARHGAP8 Rho GTPase activating protein 8 increases expression EXP thifluzamide results in increased expression of ARHGAP8 mRNA CTD PMID:33512557 NCBI chr22:44,752,575...44,862,784
Ensembl chr22:44,752,558...44,862,788
JBrowse link
G ARHGAP9 Rho GTPase activating protein 9 increases expression EXP thifluzamide results in increased expression of ARHGAP9 mRNA CTD PMID:33512557 NCBI chr12:57,472,262...57,488,824
Ensembl chr12:57,472,264...57,488,814
JBrowse link
G ARHGEF2 Rho/Rac guanine nucleotide exchange factor 2 increases expression EXP thifluzamide results in increased expression of ARHGEF2 mRNA CTD PMID:33512557 NCBI chr 1:155,946,854...155,979,617
Ensembl chr 1:155,946,851...156,007,070
JBrowse link
G ARID4A AT-rich interaction domain 4A decreases expression EXP thifluzamide results in decreased expression of ARID4A mRNA CTD PMID:33512557 NCBI chr14:58,298,385...58,373,876
Ensembl chr14:58,298,504...58,373,887
JBrowse link
G ARRDC4 arrestin domain containing 4 decreases expression EXP thifluzamide results in decreased expression of ARRDC4 mRNA CTD PMID:33512557 NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
JBrowse link
G ARSG arylsulfatase G increases expression EXP thifluzamide results in increased expression of ARSG mRNA CTD PMID:33512557 NCBI chr17:68,259,170...68,452,019
Ensembl chr17:68,259,182...68,422,731
JBrowse link
G ASNS asparagine synthetase (glutamine-hydrolyzing) increases expression EXP thifluzamide results in increased expression of ASNS mRNA CTD PMID:33512557 NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
JBrowse link
G ASS1 argininosuccinate synthase 1 increases expression EXP thifluzamide results in increased expression of ASS1 mRNA CTD PMID:33512557 NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
JBrowse link
G ATF4 activating transcription factor 4 increases expression EXP thifluzamide results in increased expression of ATF4 mRNA CTD PMID:33512557 NCBI chr22:39,514,494...39,522,686
Ensembl chr22:39,519,695...39,522,683
JBrowse link
G ATF5 activating transcription factor 5 increases expression EXP thifluzamide results in increased expression of ATF5 mRNA CTD PMID:33512557 NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
JBrowse link
G AURKB aurora kinase B increases expression EXP thifluzamide results in increased expression of AURKB mRNA CTD PMID:33512557 NCBI chr17:8,204,731...8,210,767
Ensembl chr17:8,204,733...8,210,600
JBrowse link
G BID BH3 interacting domain death agonist decreases expression EXP thifluzamide results in decreased expression of BID mRNA CTD PMID:33512557 NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
JBrowse link
G BIRC2 baculoviral IAP repeat containing 2 decreases expression EXP thifluzamide results in decreased expression of BIRC2 mRNA CTD PMID:33512557 NCBI chr11:102,347,214...102,378,670
Ensembl chr11:102,347,211...102,378,670
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 increases expression EXP thifluzamide results in increased expression of BIRC5 mRNA CTD PMID:33512557 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G BMF Bcl2 modifying factor decreases expression EXP thifluzamide results in decreased expression of BMF mRNA CTD PMID:33512557 NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
JBrowse link
G BPHL biphenyl hydrolase like decreases expression EXP thifluzamide results in decreased expression of BPHL mRNA CTD PMID:33512557 NCBI chr 6:3,118,376...3,153,599
Ensembl chr 6:3,118,374...3,153,578
JBrowse link
G BSG basigin (Ok blood group) increases expression EXP thifluzamide results in increased expression of BSG mRNA CTD PMID:33512557 NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494
JBrowse link
G C1D C1D nuclear receptor corepressor increases expression EXP thifluzamide results in increased expression of C1D mRNA CTD PMID:33512557 NCBI chr 2:68,041,130...68,063,004
Ensembl chr 2:68,041,130...68,110,948
JBrowse link
G C2CD5 C2 calcium dependent domain containing 5 decreases expression EXP thifluzamide results in decreased expression of C2CD5 mRNA CTD PMID:33512557 NCBI chr12:22,448,577...22,544,542
Ensembl chr12:22,448,583...22,544,546
JBrowse link
G CAMK2B calcium/calmodulin dependent protein kinase II beta decreases expression EXP thifluzamide results in decreased expression of CAMK2B mRNA CTD PMID:33512557 NCBI chr 7:44,217,154...44,326,167
Ensembl chr 7:44,217,150...44,334,577
JBrowse link
G CARS1 cysteinyl-tRNA synthetase 1 increases expression EXP thifluzamide results in increased expression of CARS1 mRNA CTD PMID:33512557 NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613
JBrowse link
G CBX4 chromobox 4 increases expression EXP thifluzamide results in increased expression of CBX4 mRNA CTD PMID:33512557 NCBI chr17:79,833,156...79,839,440
Ensembl chr17:79,833,156...79,839,440
JBrowse link
G CCNB2 cyclin B2 increases expression EXP thifluzamide results in increased expression of CCNB2 mRNA CTD PMID:33512557 NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
JBrowse link
G CCNE2 cyclin E2 decreases expression EXP thifluzamide results in decreased expression of CCNE2 mRNA CTD PMID:33512557 NCBI chr 8:94,880,224...94,896,671
Ensembl chr 8:94,879,770...94,896,678
JBrowse link
G CD24 CD24 molecule decreases expression EXP thifluzamide results in decreased expression of CD24 mRNA CTD PMID:33512557 NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
JBrowse link
G CDH10 cadherin 10 decreases expression EXP thifluzamide results in decreased expression of CDH10 mRNA CTD PMID:33512557 NCBI chr 5:24,487,100...24,644,978
Ensembl chr 5:24,487,100...24,644,978
JBrowse link
G CDK1 cyclin dependent kinase 1 increases expression EXP thifluzamide results in increased expression of CDK1 mRNA CTD PMID:33512557 NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
JBrowse link
G CDK5 cyclin dependent kinase 5 decreases expression EXP thifluzamide results in decreased expression of CDK5 mRNA CTD PMID:33512557 NCBI chr 7:151,053,815...151,057,897
Ensembl chr 7:151,053,815...151,057,897
JBrowse link
G CDKN3 cyclin dependent kinase inhibitor 3 increases expression EXP thifluzamide results in increased expression of CDKN3 mRNA CTD PMID:33512557 NCBI chr14:54,396,873...54,420,218
Ensembl chr14:54,396,849...54,420,218
JBrowse link
G CEBPB CCAAT enhancer binding protein beta increases expression EXP thifluzamide results in increased expression of CEBPB mRNA CTD PMID:33512557 NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
JBrowse link
G CEP55 centrosomal protein 55 increases expression EXP thifluzamide results in increased expression of CEP55 mRNA CTD PMID:33512557 NCBI chr10:93,496,612...93,529,094
Ensembl chr10:93,496,612...93,529,092
JBrowse link
G CHAC1 ChaC glutathione specific gamma-glutamylcyclotransferase 1 increases expression EXP thifluzamide results in increased expression of CHAC1 mRNA CTD PMID:33512557 NCBI chr15:40,942,137...40,956,518
Ensembl chr15:40,952,962...40,956,512
JBrowse link
G CHKA choline kinase alpha increases expression EXP thifluzamide results in increased expression of CHKA mRNA CTD PMID:33512557 NCBI chr11:68,052,859...68,121,389
Ensembl chr11:68,052,859...68,121,444
JBrowse link
G CHRNA4 cholinergic receptor nicotinic alpha 4 subunit decreases expression EXP thifluzamide results in decreased expression of CHRNA4 mRNA CTD PMID:33512557 NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401
JBrowse link
G CKS2 CDC28 protein kinase regulatory subunit 2 increases expression EXP thifluzamide results in increased expression of CKS2 mRNA CTD PMID:33512557 NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
JBrowse link
G CLDN5 claudin 5 decreases expression EXP thifluzamide results in decreased expression of CLDN5 mRNA CTD PMID:33512557 NCBI chr22:19,523,024...19,525,337
Ensembl chr22:19,523,024...19,527,545
JBrowse link
G CLIC4 chloride intracellular channel 4 increases expression EXP thifluzamide results in increased expression of CLIC4 mRNA CTD PMID:33512557 NCBI chr 1:24,745,447...24,844,321
Ensembl chr 1:24,745,382...24,844,321
JBrowse link
G CPNE3 copine 3 decreases expression EXP thifluzamide results in decreased expression of CPNE3 mRNA CTD PMID:33512557 NCBI chr 8:86,514,422...86,561,498
Ensembl chr 8:86,514,435...86,561,498
JBrowse link
G CPSF4 cleavage and polyadenylation specific factor 4 decreases expression EXP thifluzamide results in decreased expression of CPSF4 mRNA CTD PMID:33512557 NCBI chr 7:99,438,912...99,457,373
Ensembl chr 7:99,438,922...99,457,373
JBrowse link
G CREG1 cellular repressor of E1A stimulated genes 1 increases expression EXP thifluzamide results in increased expression of CREG1 mRNA CTD PMID:33512557 NCBI chr 1:167,541,013...167,553,762
Ensembl chr 1:167,529,117...167,553,805
JBrowse link
G CRTAP cartilage associated protein increases expression EXP thifluzamide results in increased expression of CRTAP mRNA CTD PMID:33512557 NCBI chr 3:33,114,014...33,147,773
Ensembl chr 3:33,114,014...33,147,773
JBrowse link
G CTH cystathionine gamma-lyase increases expression EXP thifluzamide results in increased expression of CTH mRNA CTD PMID:33512557 NCBI chr 1:70,411,268...70,441,949
Ensembl chr 1:70,411,218...70,439,851
JBrowse link
G CTNND1 catenin delta 1 decreases expression EXP thifluzamide results in decreased expression of CTNND1 mRNA CTD PMID:33512557 NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
JBrowse link
G CTSS cathepsin S decreases expression EXP thifluzamide results in decreased expression of CTSS mRNA CTD PMID:33512557 NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
JBrowse link
G CXCR4 C-X-C motif chemokine receptor 4 decreases expression EXP thifluzamide results in decreased expression of CXCR4 mRNA CTD PMID:33512557 NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,118,149
JBrowse link
G DAAM1 dishevelled associated activator of morphogenesis 1 decreases expression EXP thifluzamide results in decreased expression of DAAM1 mRNA CTD PMID:33512557 NCBI chr14:59,188,657...59,371,405
Ensembl chr14:59,188,646...59,371,405
JBrowse link
G DCX doublecortin decreases expression EXP thifluzamide results in decreased expression of DCX mRNA CTD PMID:33512557 NCBI chr  X:111,293,779...111,412,205
Ensembl chr  X:111,293,779...111,412,429
JBrowse link
G DDC dopa decarboxylase decreases expression EXP thifluzamide results in decreased expression of DDC mRNA CTD PMID:33512557 NCBI chr 7:50,458,436...50,565,460
Ensembl chr 7:50,458,436...50,565,405
JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression EXP thifluzamide results in increased expression of DDIT3 mRNA CTD PMID:33512557 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
JBrowse link
G DDIT4 DNA damage inducible transcript 4 increases expression EXP thifluzamide results in increased expression of DDIT4 mRNA CTD PMID:33512557 NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
JBrowse link
G DEPDC1B DEP domain containing 1B increases expression EXP thifluzamide results in increased expression of DEPDC1B mRNA CTD PMID:33512557 NCBI chr 5:60,596,912...60,700,166
Ensembl chr 5:60,596,912...60,700,190
JBrowse link
G DNM1 dynamin 1 decreases expression EXP thifluzamide results in decreased expression of DNM1 mRNA CTD PMID:33512557 NCBI chr 9:128,203,379...128,255,244
Ensembl chr 9:128,191,655...128,255,248
JBrowse link
G DPM2 dolichyl-phosphate mannosyltransferase subunit 2, regulatory increases expression EXP thifluzamide results in increased expression of DPM2 mRNA CTD PMID:33512557 NCBI chr 9:127,935,099...127,937,854
Ensembl chr 9:127,935,099...127,937,854
JBrowse link
G DRD2 dopamine receptor D2 decreases expression EXP thifluzamide results in decreased expression of DRD2 mRNA CTD PMID:33512557 NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
JBrowse link
G DUSP14 dual specificity phosphatase 14 increases expression EXP thifluzamide results in increased expression of DUSP14 mRNA CTD PMID:33512557 NCBI chr17:37,488,561...37,513,501
Ensembl chr17:37,489,891...37,513,501
JBrowse link
G DUSP22 dual specificity phosphatase 22 increases expression EXP thifluzamide results in increased expression of DUSP22 mRNA CTD PMID:33512557 NCBI chr 6:292,459...351,355
Ensembl chr 6:291,630...351,355
JBrowse link
G DUSP4 dual specificity phosphatase 4 increases expression EXP thifluzamide results in increased expression of DUSP4 mRNA CTD PMID:33512557 NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
JBrowse link
G EEA1 early endosome antigen 1 increases expression EXP thifluzamide results in increased expression of EEA1 mRNA CTD PMID:33512557 NCBI chr12:92,770,637...92,975,228
Ensembl chr12:92,770,637...92,929,331
JBrowse link
G EGR1 early growth response 1 increases expression EXP thifluzamide results in increased expression of EGR1 mRNA CTD PMID:33512557 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
JBrowse link
G EIF1 eukaryotic translation initiation factor 1 increases expression EXP thifluzamide results in increased expression of EIF1 mRNA CTD PMID:33512557 NCBI chr17:41,688,885...41,692,668
Ensembl chr17:41,688,885...41,692,668
JBrowse link
G EIF2S2 eukaryotic translation initiation factor 2 subunit beta increases expression EXP thifluzamide results in increased expression of EIF2S2 mRNA CTD PMID:33512557 NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,243
JBrowse link
G EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 increases expression EXP thifluzamide results in increased expression of EIF4EBP1 mRNA CTD PMID:33512557 NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
JBrowse link
G ELMOD1 ELMO domain containing 1 decreases expression EXP thifluzamide results in decreased expression of ELMOD1 mRNA CTD PMID:33512557 NCBI chr11:107,591,009...107,666,779
Ensembl chr11:107,591,091...107,666,779
JBrowse link
G EPHB2 EPH receptor B2 decreases expression EXP thifluzamide results in decreased expression of EPHB2 mRNA CTD PMID:33512557 NCBI chr 1:22,710,770...22,921,500
Ensembl chr 1:22,710,839...22,921,500
JBrowse link
G EPS15 epidermal growth factor receptor pathway substrate 15 increases expression EXP thifluzamide results in increased expression of EPS15 mRNA CTD PMID:33512557 NCBI chr 1:51,354,263...51,519,275
Ensembl chr 1:51,354,263...51,519,266
JBrowse link
G ERO1A endoplasmic reticulum oxidoreductase 1 alpha increases expression EXP thifluzamide results in increased expression of ERO1A mRNA CTD PMID:33512557 NCBI chr14:52,639,915...52,695,750
Ensembl chr14:52,639,915...52,695,900
JBrowse link
G ETNK1 ethanolamine kinase 1 decreases expression EXP thifluzamide results in decreased expression of ETNK1 mRNA CTD PMID:33512557 NCBI chr12:22,625,145...22,690,665
Ensembl chr12:22,625,075...22,690,665
JBrowse link
G ETS1 ETS proto-oncogene 1, transcription factor increases expression EXP thifluzamide results in increased expression of ETS1 mRNA CTD PMID:33512557 NCBI chr11:128,458,765...128,587,593
Ensembl chr11:128,458,761...128,587,558
JBrowse link
G ETV1 ETS variant transcription factor 1 decreases expression EXP thifluzamide results in decreased expression of ETV1 mRNA CTD PMID:33512557 NCBI chr 7:13,891,229...13,991,425
Ensembl chr 7:13,891,229...13,991,425
JBrowse link
G EXOSC4 exosome component 4 decreases expression EXP thifluzamide results in decreased expression of EXOSC4 mRNA CTD PMID:33512557 NCBI chr 8:144,064,061...144,080,648
Ensembl chr 8:144,078,648...144,080,648
JBrowse link
G EXOSC8 exosome component 8 increases expression EXP thifluzamide results in increased expression of EXOSC8 mRNA CTD PMID:33512557 NCBI chr13:37,000,373...37,009,614
Ensembl chr13:36,998,816...37,025,881
JBrowse link
G FAM72A family with sequence similarity 72 member A increases expression EXP thifluzamide results in increased expression of FAM72A mRNA CTD PMID:33512557 NCBI chr 1:206,186,179...206,205,773
Ensembl chr 1:206,186,179...206,204,414
JBrowse link
G FGF8 fibroblast growth factor 8 decreases expression EXP thifluzamide results in decreased expression of FGF8 mRNA CTD PMID:33512557 NCBI chr10:101,770,109...101,780,369
Ensembl chr10:101,770,109...101,780,371
JBrowse link
G FIBIN fin bud initiation factor homolog increases expression EXP thifluzamide results in increased expression of FIBIN mRNA CTD PMID:33512557 NCBI chr11:26,994,112...26,997,087
Ensembl chr11:26,994,112...26,997,087
JBrowse link
G FLNA filamin A increases expression EXP thifluzamide results in increased expression of FLNA mRNA CTD PMID:33512557 NCBI chr  X:154,348,531...154,374,634
Ensembl chr  X:154,348,524...154,374,634
JBrowse link
G FTH1 ferritin heavy chain 1 increases expression EXP thifluzamide results in increased expression of FTH1 mRNA CTD PMID:33512557 NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
JBrowse link
G FTL ferritin light chain increases expression EXP thifluzamide results in increased expression of FTL mRNA CTD PMID:33512557 NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha increases expression EXP thifluzamide results in increased expression of GADD45A mRNA CTD PMID:33512557 NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
JBrowse link
G GADD45B growth arrest and DNA damage inducible beta increases expression EXP thifluzamide results in increased expression of GADD45B mRNA CTD PMID:33512557 NCBI chr19:2,476,127...2,478,259
Ensembl chr19:2,476,122...2,478,259
JBrowse link
G GALNT3 polypeptide N-acetylgalactosaminyltransferase 3 decreases expression EXP thifluzamide results in decreased expression of GALNT3 mRNA CTD PMID:33512557 NCBI chr 2:165,747,588...165,796,352
Ensembl chr 2:165,747,588...165,794,659
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression EXP thifluzamide results in increased expression of GCLM mRNA CTD PMID:33512557 NCBI chr 1:93,885,199...93,910,370
Ensembl chr 1:93,885,199...93,909,456
JBrowse link
G GDF15 growth differentiation factor 15 increases expression EXP thifluzamide results in increased expression of GDF15 mRNA CTD PMID:33512557 NCBI chr19:18,382,170...18,389,176
Ensembl chr19:18,374,731...18,389,176
JBrowse link
G GLDC glycine decarboxylase decreases expression EXP thifluzamide results in decreased expression of GLDC mRNA CTD PMID:33512557 NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
JBrowse link
G GLRX glutaredoxin decreases expression EXP thifluzamide results in decreased expression of GLRX mRNA CTD PMID:33512557 NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
JBrowse link
G GMIP GEM interacting protein decreases expression EXP thifluzamide results in decreased expression of GMIP mRNA CTD PMID:33512557 NCBI chr19:19,629,476...19,643,657
Ensembl chr19:19,629,476...19,643,657
JBrowse link
G GNAI2 G protein subunit alpha i2 decreases expression EXP thifluzamide results in decreased expression of GNAI2 mRNA CTD PMID:33512557 NCBI chr 3:50,227,068...50,259,362
Ensembl chr 3:50,226,292...50,259,362
JBrowse link
G GNB3 G protein subunit beta 3 decreases expression EXP thifluzamide results in decreased expression of GNB3 mRNA CTD PMID:33512557 NCBI chr12:6,840,922...6,847,393
Ensembl chr12:6,839,954...6,847,393
JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 increases expression EXP thifluzamide results in increased expression of GOT1 mRNA CTD PMID:33512557 NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
JBrowse link
G GRB10 growth factor receptor bound protein 10 increases expression EXP thifluzamide results in increased expression of GRB10 mRNA CTD PMID:33512557 NCBI chr 7:50,590,068...50,793,453
Ensembl chr 7:50,590,063...50,793,462
JBrowse link
G GRIA2 glutamate ionotropic receptor AMPA type subunit 2 decreases expression EXP thifluzamide results in decreased expression of GRIA2 mRNA CTD PMID:33512557 NCBI chr 4:157,220,120...157,370,583
Ensembl chr 4:157,204,182...157,366,075
JBrowse link
G GRIN2D glutamate ionotropic receptor NMDA type subunit 2D decreases expression EXP thifluzamide results in decreased expression of GRIN2D mRNA CTD PMID:33512557 NCBI chr19:48,393,668...48,444,937
Ensembl chr19:48,393,668...48,444,931
JBrowse link
G GRM4 glutamate metabotropic receptor 4 decreases expression EXP thifluzamide results in decreased expression of GRM4 mRNA CTD PMID:33512557 NCBI chr 6:34,018,643...34,155,622
Ensembl chr 6:34,018,643...34,155,622
JBrowse link
G GSR glutathione-disulfide reductase increases expression EXP thifluzamide results in increased expression of GSR mRNA CTD PMID:33512557 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G GSTM2 glutathione S-transferase mu 2 decreases expression EXP thifluzamide results in decreased expression of GSTM2 mRNA CTD PMID:33512557 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
JBrowse link
G H1-0 H1.0 linker histone increases expression EXP thifluzamide results in increased expression of H1-0 mRNA CTD PMID:33512557 NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
JBrowse link
G H1-2 H1.2 linker histone, cluster member increases expression EXP thifluzamide results in increased expression of H1-2 mRNA CTD PMID:33512557 NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
JBrowse link
G H2AC11 H2A clustered histone 11 increases expression EXP thifluzamide results in increased expression of H2AC11 mRNA CTD PMID:33512557 NCBI chr 6:27,133,043...27,133,535
Ensembl chr 6:27,133,043...27,133,535
JBrowse link
G H2AC15 H2A clustered histone 15 increases expression EXP thifluzamide results in increased expression of H2AC15 mRNA CTD PMID:33512557 NCBI chr 6:27,837,880...27,838,375
Ensembl chr 6:27,837,880...27,838,375
JBrowse link
G H2AC19 H2A clustered histone 19 increases expression EXP thifluzamide results in increased expression of H2AC19 mRNA CTD PMID:33512557 NCBI chr 1:149,851,061...149,851,594
Ensembl chr 1:149,851,061...149,851,594
JBrowse link
G H2AC6 H2A clustered histone 6 increases expression EXP thifluzamide results in increased expression of H2AC6 mRNA CTD PMID:33512557 NCBI chr 6:26,124,172...26,124,690
Ensembl chr 6:26,124,145...26,139,116
JBrowse link
G H2BC3 H2B clustered histone 3 increases expression EXP thifluzamide results in increased expression of H2BC3 mRNA CTD PMID:33512557 NCBI chr 6:26,043,227...26,043,713
Ensembl chr 6:26,043,227...26,043,713
JBrowse link
G H2BC5 H2B clustered histone 5 increases expression EXP thifluzamide results in increased expression of H2BC5 mRNA CTD PMID:33512557 NCBI chr 6:26,158,008...26,171,349
Ensembl chr 6:26,158,122...26,171,349
JBrowse link
G H3C10 H3 clustered histone 10 increases expression EXP thifluzamide results in increased expression of H3C10 mRNA CTD PMID:33512557 NCBI chr 6:27,810,051...27,810,536
Ensembl chr 6:27,810,051...27,811,300
JBrowse link
G H3C2 H3 clustered histone 2 increases expression EXP thifluzamide results in increased expression of H3C2 mRNA CTD PMID:33512557 NCBI chr 6:26,031,589...26,032,099
Ensembl chr 6:26,031,589...26,032,099
JBrowse link
G H3C3 H3 clustered histone 3 increases expression EXP thifluzamide results in increased expression of H3C3 mRNA CTD PMID:33512557 NCBI chr 6:26,045,384...26,045,869
Ensembl chr 6:26,045,384...26,045,869
JBrowse link
G H3C4 H3 clustered histone 4 increases expression EXP thifluzamide results in increased expression of H3C4 mRNA CTD PMID:33512557 NCBI chr 6:26,196,784...26,199,293
Ensembl chr 6:26,196,784...26,197,286
JBrowse link
G HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression EXP thifluzamide results in increased expression of HERPUD1 mRNA CTD PMID:33512557 NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
JBrowse link
G HES5 hes family bHLH transcription factor 5 decreases expression EXP thifluzamide results in decreased expression of HES5 mRNA CTD PMID:33512557 NCBI chr 1:2,528,745...2,530,554
Ensembl chr 1:2,528,745...2,530,263
JBrowse link
G HHIP hedgehog interacting protein increases expression EXP thifluzamide results in increased expression of HHIP mRNA CTD PMID:33512557 NCBI chr 4:144,646,154...144,745,271
Ensembl chr 4:144,646,156...144,745,271
JBrowse link
G HMOX1 heme oxygenase 1 increases expression EXP thifluzamide results in increased expression of HMOX1 mRNA CTD PMID:33512557 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HNRNPM heterogeneous nuclear ribonucleoprotein M decreases expression EXP thifluzamide results in decreased expression of HNRNPM mRNA CTD PMID:33512557 NCBI chr19:8,444,575...8,489,114
Ensembl chr19:8,444,767...8,489,114
JBrowse link
G HSD17B8 hydroxysteroid 17-beta dehydrogenase 8 decreases expression EXP thifluzamide results in decreased expression of HSD17B8 mRNA CTD PMID:33512557 NCBI chr 6:33,204,655...33,206,831
Ensembl chr 6:33,204,655...33,206,831
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 increases expression EXP thifluzamide results in increased expression of HSPA8 mRNA CTD PMID:33512557 NCBI chr11:123,057,489...123,062,366
Ensembl chr11:123,057,489...123,063,230
JBrowse link
G HYOU1 hypoxia up-regulated 1 increases expression EXP thifluzamide results in increased expression of HYOU1 mRNA CTD PMID:33512557 NCBI chr11:119,044,187...119,057,205
Ensembl chr11:119,044,188...119,057,227
JBrowse link
G IDE insulin degrading enzyme increases expression EXP thifluzamide results in increased expression of IDE mRNA CTD PMID:33512557 NCBI chr10:92,451,684...92,574,093
Ensembl chr10:92,451,684...92,574,096
JBrowse link
G IDH3A isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha increases expression EXP thifluzamide results in increased expression of IDH3A mRNA CTD PMID:33512557 NCBI chr15:78,149,362...78,171,945
Ensembl chr15:78,131,498...78,171,945
JBrowse link
G IFI44 interferon induced protein 44 decreases expression EXP thifluzamide results in decreased expression of IFI44 mRNA CTD PMID:33512557 NCBI chr 1:78,648,943...78,664,078
Ensembl chr 1:78,649,796...78,664,078
JBrowse link
G IFI6 interferon alpha inducible protein 6 decreases expression EXP thifluzamide results in decreased expression of IFI6 mRNA CTD PMID:33512557 NCBI chr 1:27,666,061...27,672,229
Ensembl chr 1:27,666,064...27,672,212
JBrowse link
G IFITM2 interferon induced transmembrane protein 2 decreases expression EXP thifluzamide results in decreased expression of IFITM2 mRNA CTD PMID:33512557 NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397
JBrowse link
G IFITM3 interferon induced transmembrane protein 3 decreases expression EXP thifluzamide results in decreased expression of IFITM3 mRNA CTD PMID:33512557 NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
JBrowse link
G IFRD1 interferon related developmental regulator 1 increases expression EXP thifluzamide results in increased expression of IFRD1 mRNA CTD PMID:33512557 NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
JBrowse link
G IKZF1 IKAROS family zinc finger 1 decreases expression EXP thifluzamide results in decreased expression of IKZF1 mRNA CTD PMID:33512557 NCBI chr 7:50,303,453...50,405,101
Ensembl chr 7:50,304,068...50,405,101
JBrowse link
G INHBE inhibin subunit beta E increases expression EXP thifluzamide results in increased expression of INHBE mRNA CTD PMID:33512557 NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
JBrowse link
G IPO5 importin 5 increases expression EXP thifluzamide results in increased expression of IPO5 mRNA CTD PMID:33512557 NCBI chr13:97,953,641...98,024,296
Ensembl chr13:97,953,658...98,024,296
JBrowse link
G IRF1 interferon regulatory factor 1 increases expression EXP thifluzamide results in increased expression of IRF1 mRNA CTD PMID:33512557 NCBI chr 5:132,481,609...132,490,789
Ensembl chr 5:132,440,440...132,508,719
JBrowse link
G ISL1 ISL LIM homeobox 1 decreases expression EXP thifluzamide results in decreased expression of ISL1 mRNA CTD PMID:33512557 NCBI chr 5:51,383,448...51,394,730
Ensembl chr 5:51,383,448...51,394,730
JBrowse link
G ITPR1 inositol 1,4,5-trisphosphate receptor type 1 increases expression EXP thifluzamide results in increased expression of ITPR1 mRNA CTD PMID:33512557 NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
JBrowse link
G ITPR2 inositol 1,4,5-trisphosphate receptor type 2 decreases expression EXP thifluzamide results in decreased expression of ITPR2 mRNA CTD PMID:33512557 NCBI chr12:26,335,352...26,833,197
Ensembl chr12:26,335,352...26,833,194
JBrowse link
G JMJD6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase increases expression EXP thifluzamide results in increased expression of JMJD6 mRNA CTD PMID:33512557 NCBI chr17:76,712,830...76,726,783
Ensembl chr17:76,712,832...76,726,799
JBrowse link
G KARS1 lysyl-tRNA synthetase 1 decreases expression EXP thifluzamide results in decreased expression of KARS1 mRNA CTD PMID:33512557 NCBI chr16:75,627,724...75,647,665
Ensembl chr16:75,627,474...75,648,643
JBrowse link
G KCNQ2 potassium voltage-gated channel subfamily Q member 2 decreases expression EXP thifluzamide results in decreased expression of KCNQ2 mRNA CTD PMID:33512557 NCBI chr20:63,400,208...63,472,655
Ensembl chr20:63,400,208...63,472,677
JBrowse link
G KDELR2 KDEL endoplasmic reticulum protein retention receptor 2 increases expression EXP thifluzamide results in increased expression of KDELR2 mRNA CTD PMID:33512557 NCBI chr 7:6,461,089...6,484,152
Ensembl chr 7:6,445,953...6,484,190
JBrowse link
G KIF13A kinesin family member 13A decreases expression EXP thifluzamide results in decreased expression of KIF13A mRNA CTD PMID:33512557 NCBI chr 6:17,759,126...17,987,635
Ensembl chr 6:17,759,183...17,987,635
JBrowse link
G KIF20A kinesin family member 20A increases expression EXP thifluzamide results in increased expression of KIF20A mRNA CTD PMID:33512557 NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
JBrowse link
G KLHL24 kelch like family member 24 decreases expression EXP thifluzamide results in decreased expression of KLHL24 mRNA CTD PMID:33512557 NCBI chr 3:183,635,619...183,684,519
Ensembl chr 3:183,635,610...183,684,519
JBrowse link
G L1CAM L1 cell adhesion molecule decreases expression EXP thifluzamide results in decreased expression of L1CAM mRNA CTD PMID:33512557 NCBI chr  X:153,861,514...153,886,173
Ensembl chr  X:153,861,514...153,886,173
JBrowse link
G LAMP3 lysosomal associated membrane protein 3 increases expression EXP thifluzamide results in increased expression of LAMP3 mRNA CTD PMID:33512557 NCBI chr 3:183,122,215...183,162,761
Ensembl chr 3:183,122,215...183,163,839
JBrowse link
G LMOD1 leiomodin 1 decreases expression EXP thifluzamide results in decreased expression of LMOD1 mRNA CTD PMID:33512557 NCBI chr 1:201,896,456...201,946,548
Ensembl chr 1:201,896,456...201,946,588
JBrowse link
G LOXL1 lysyl oxidase like 1 decreases expression EXP thifluzamide results in decreased expression of LOXL1 mRNA CTD PMID:33512557 NCBI chr15:73,926,462...73,952,137
Ensembl chr15:73,925,989...73,952,137
JBrowse link
G LPCAT1 lysophosphatidylcholine acyltransferase 1 decreases expression EXP thifluzamide results in decreased expression of LPCAT1 mRNA CTD PMID:33512557 NCBI chr 5:1,461,427...1,523,960
Ensembl chr 5:1,456,480...1,523,962
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta increases expression EXP thifluzamide results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
JBrowse link
G MAP2 microtubule associated protein 2 decreases expression EXP thifluzamide results in decreased expression of MAP2 mRNA CTD PMID:33512557 NCBI chr 2:209,424,047...209,734,118
Ensembl chr 2:209,424,047...209,734,118
JBrowse link
G MAP6 microtubule associated protein 6 decreases expression EXP thifluzamide results in decreased expression of MAP6 mRNA CTD PMID:33512557 NCBI chr11:75,586,914...75,669,038
Ensembl chr11:75,586,918...75,669,038
JBrowse link
G MDK midkine increases expression EXP thifluzamide results in increased expression of MDK mRNA CTD PMID:33512557 NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
JBrowse link
G ME1 malic enzyme 1 increases expression EXP thifluzamide results in increased expression of ME1 mRNA CTD PMID:33512557 NCBI chr 6:83,210,402...83,431,078
Ensembl chr 6:83,210,402...83,431,051
JBrowse link
G METRN meteorin, glial cell differentiation regulator decreases expression EXP thifluzamide results in decreased expression of METRN mRNA CTD PMID:33512557 NCBI chr16:715,118...719,655
Ensembl chr16:715,118...719,655
JBrowse link
G MOK MOK protein kinase increases expression EXP thifluzamide results in increased expression of MOK mRNA CTD PMID:33512557 NCBI chr14:102,224,441...102,305,191
Ensembl chr14:102,224,500...102,305,190
JBrowse link
G MSI2 musashi RNA binding protein 2 decreases expression EXP thifluzamide results in decreased expression of MSI2 mRNA CTD PMID:33512557 NCBI chr17:57,255,851...57,684,689
Ensembl chr17:57,255,851...57,684,689
JBrowse link
G MT-ND6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 decreases expression EXP thifluzamide results in decreased expression of ND6 mRNA CTD PMID:33512557 NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673
JBrowse link
G MT2A metallothionein 2A increases expression EXP thifluzamide results in increased expression of MT2A mRNA CTD PMID:33512557 NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
JBrowse link
G MTHFD2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression EXP thifluzamide results in increased expression of MTHFD2 mRNA CTD PMID:33512557 NCBI chr 2:74,198,591...74,217,565
Ensembl chr 2:74,186,172...74,217,565
JBrowse link
G MYB MYB proto-oncogene, transcription factor decreases expression EXP thifluzamide results in decreased expression of MYB mRNA CTD PMID:33512557 NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor increases expression EXP thifluzamide results in increased expression of MYC mRNA CTD PMID:33512557 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G MYL4 myosin light chain 4 decreases expression EXP thifluzamide results in decreased expression of MYL4 mRNA CTD PMID:33512557 NCBI chr17:47,209,017...47,227,650
Ensembl chr17:47,200,446...47,223,679
JBrowse link
G NAV1 neuron navigator 1 decreases expression EXP thifluzamide results in decreased expression of NAV1 mRNA CTD PMID:33512557 NCBI chr 1:201,539,127...201,826,969
Ensembl chr 1:201,539,127...201,826,969
JBrowse link
G NCAN neurocan decreases expression EXP thifluzamide results in decreased expression of NCAN mRNA CTD PMID:33512557 NCBI chr19:19,211,958...19,252,233
Ensembl chr19:19,211,958...19,252,233
JBrowse link
G NEFL neurofilament light chain decreases expression EXP thifluzamide results in decreased expression of NEFL mRNA CTD PMID:33512557 NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
JBrowse link
G NEK2 NIMA related kinase 2 increases expression EXP thifluzamide results in increased expression of NEK2 mRNA CTD PMID:33512557 NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 increases expression EXP thifluzamide results in increased expression of NQO1 mRNA CTD PMID:33512557 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NR2F1 nuclear receptor subfamily 2 group F member 1 decreases expression EXP thifluzamide results in decreased expression of NR2F1 mRNA CTD PMID:33512557 NCBI chr 5:93,583,222...93,594,613
Ensembl chr 5:93,583,222...93,594,611
JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 increases expression EXP thifluzamide results in increased expression of NR3C1 mRNA CTD PMID:33512557 NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
JBrowse link
G NR4A2 nuclear receptor subfamily 4 group A member 2 decreases expression EXP thifluzamide results in decreased expression of NR4A2 mRNA CTD PMID:33512557 NCBI chr 2:156,324,432...156,332,724
Ensembl chr 2:156,324,437...156,342,348
JBrowse link
G NRCAM neuronal cell adhesion molecule decreases expression EXP thifluzamide results in decreased expression of NRCAM mRNA CTD PMID:33512557 NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
JBrowse link
G NRXN1 neurexin 1 decreases expression EXP thifluzamide results in decreased expression of NRXN1 mRNA CTD PMID:33512557 NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575
JBrowse link
G OLFML2B olfactomedin like 2B decreases expression EXP thifluzamide results in decreased expression of OLFML2B mRNA CTD PMID:33512557 NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869
JBrowse link
G ORMDL3 ORMDL sphingolipid biosynthesis regulator 3 decreases expression EXP thifluzamide results in decreased expression of ORMDL3 mRNA CTD PMID:33512557 NCBI chr17:39,921,041...39,927,601
Ensembl chr17:39,921,041...39,927,601
JBrowse link
G P4HA2 prolyl 4-hydroxylase subunit alpha 2 increases expression EXP thifluzamide results in increased expression of P4HA2 mRNA CTD PMID:33512557 NCBI chr 5:132,190,147...132,227,853
Ensembl chr 5:132,190,147...132,295,315
JBrowse link
G PCDH8 protocadherin 8 increases expression EXP thifluzamide results in increased expression of PCDH8 mRNA CTD PMID:33512557 NCBI chr13:52,842,889...52,848,640
Ensembl chr13:52,842,889...52,848,641
JBrowse link
G PDGFB platelet derived growth factor subunit B decreases expression EXP thifluzamide results in decreased expression of PDGFB mRNA CTD PMID:33512557 NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 decreases expression EXP thifluzamide results in decreased expression of PEBP1 mRNA CTD PMID:33512557 NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584
JBrowse link
G PEG10 paternally expressed 10 decreases expression EXP thifluzamide results in decreased expression of PEG10 mRNA CTD PMID:33512557 NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
JBrowse link
G PGA5 pepsinogen A5 increases expression EXP thifluzamide results in increased expression of PGA5 mRNA CTD PMID:33512557 NCBI chr11:61,241,175...61,251,444
Ensembl chr11:61,241,175...61,251,444
JBrowse link
G PHGDH phosphoglycerate dehydrogenase increases expression EXP thifluzamide results in increased expression of PHGDH mRNA CTD PMID:33512557 NCBI chr 1:119,711,934...119,744,218
Ensembl chr 1:119,648,411...119,744,218
JBrowse link
G PHLDA1 pleckstrin homology like domain family A member 1 decreases expression EXP thifluzamide results in decreased expression of PHLDA1 mRNA CTD PMID:33512557 NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
JBrowse link
G PINK1 PTEN induced kinase 1 decreases expression EXP thifluzamide results in decreased expression of PINK1 mRNA CTD PMID:33512557 NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
JBrowse link
G PLCB3 phospholipase C beta 3 decreases expression EXP thifluzamide results in decreased expression of PLCB3 mRNA CTD PMID:33512557 NCBI chr11:64,251,530...64,269,452
Ensembl chr11:64,251,530...64,269,150
JBrowse link
G PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression EXP thifluzamide results in increased expression of PMAIP1 mRNA CTD PMID:33512557 NCBI chr18:59,899,996...59,904,305
Ensembl chr18:59,899,996...59,904,305
JBrowse link
G POU4F2 POU class 4 homeobox 2 decreases expression EXP thifluzamide results in decreased expression of POU4F2 mRNA CTD PMID:33512557 NCBI chr 4:146,638,893...146,642,474
Ensembl chr 4:146,638,893...146,642,474
JBrowse link
G PPP1R17 protein phosphatase 1 regulatory subunit 17 decreases expression EXP thifluzamide results in decreased expression of PPP1R17 mRNA CTD PMID:33512557 NCBI chr 7:31,687,215...31,710,158
Ensembl chr 7:31,687,215...31,708,455
JBrowse link
G PRR11 proline rich 11 increases expression EXP thifluzamide results in increased expression of PRR11 mRNA CTD PMID:33512557 NCBI chr17:59,155,355...59,206,709
Ensembl chr17:59,155,732...59,206,709
JBrowse link
G PSAT1 phosphoserine aminotransferase 1 increases expression EXP thifluzamide results in increased expression of PSAT1 mRNA CTD PMID:33512557 NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
JBrowse link
G PTPRF protein tyrosine phosphatase receptor type F decreases expression EXP thifluzamide results in decreased expression of PTPRF mRNA CTD PMID:33512557 NCBI chr 1:43,522,238...43,623,666
Ensembl chr 1:43,525,187...43,623,666
JBrowse link
G RAB31 RAB31, member RAS oncogene family decreases expression EXP thifluzamide results in decreased expression of RAB31 mRNA CTD PMID:33512557 NCBI chr18:9,708,187...9,862,551
Ensembl chr18:9,708,275...9,862,551
JBrowse link
G RBX1 ring-box 1 decreases expression EXP thifluzamide results in decreased expression of RBX1 mRNA CTD PMID:33512557 NCBI chr22:40,951,378...40,973,309
Ensembl chr22:40,951,347...40,973,309
JBrowse link
G RELN reelin decreases expression EXP thifluzamide results in decreased expression of RELN mRNA CTD PMID:33512557 NCBI chr 7:103,471,789...103,989,658
Ensembl chr 7:103,471,381...103,989,658
JBrowse link
G RPL28 ribosomal protein L28 increases expression EXP thifluzamide results in increased expression of RPL28 mRNA CTD PMID:33512557 NCBI chr19:55,385,932...55,403,342
Ensembl chr19:55,385,932...55,403,250
JBrowse link
G RPSA ribosomal protein SA increases expression EXP thifluzamide results in increased expression of RPSA mRNA CTD PMID:33512557 NCBI chr 3:39,406,720...39,412,542
Ensembl chr 3:39,406,716...39,412,542
JBrowse link
G RSL24D1 ribosomal L24 domain containing 1 increases expression EXP thifluzamide results in increased expression of RSL24D1 mRNA CTD PMID:33512557 NCBI chr15:55,180,806...55,196,941
Ensembl chr15:55,180,806...55,197,049
JBrowse link
G RXYLT1 ribitol xylosyltransferase 1 increases expression EXP thifluzamide results in increased expression of RXYLT1 mRNA CTD PMID:33512557 NCBI chr12:63,779,831...63,809,562
Ensembl chr12:63,779,833...63,809,792
JBrowse link
G SATB1 SATB homeobox 1 decreases expression EXP thifluzamide results in decreased expression of SATB1 mRNA CTD PMID:33512557 NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,588
JBrowse link
G SEL1L SEL1L adaptor subunit of ERAD E3 ubiquitin ligase increases expression EXP thifluzamide results in increased expression of SEL1L mRNA CTD PMID:33512557 NCBI chr14:81,471,547...81,533,853
Ensembl chr14:81,471,547...81,533,853
JBrowse link
G SEMA6A semaphorin 6A decreases expression EXP thifluzamide results in decreased expression of SEMA6A mRNA CTD PMID:33512557 NCBI chr 5:116,443,555...116,574,823
Ensembl chr 5:116,443,555...116,574,823
JBrowse link
G SEPHS2 selenophosphate synthetase 2 increases expression EXP thifluzamide results in increased expression of SEPHS2 mRNA CTD PMID:33512557 NCBI chr16:30,443,631...30,445,874
Ensembl chr16:30,443,631...30,445,874
JBrowse link
G SERPINE2 serpin family E member 2 increases expression EXP thifluzamide results in increased expression of SERPINE2 mRNA CTD PMID:33512557 NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
JBrowse link
G SESN2 sestrin 2 increases expression EXP thifluzamide results in increased expression of SESN2 mRNA CTD PMID:33512557 NCBI chr 1:28,259,452...28,282,491
Ensembl chr 1:28,259,518...28,282,491
JBrowse link
G SGCB sarcoglycan beta decreases expression EXP thifluzamide results in decreased expression of SGCB mRNA CTD PMID:33512557 NCBI chr 4:52,020,706...52,038,299
Ensembl chr 4:52,020,706...52,038,299
JBrowse link
G SLC17A6 solute carrier family 17 member 6 decreases expression EXP thifluzamide results in decreased expression of SLC17A6 mRNA CTD PMID:33512557 NCBI chr11:22,338,381...22,379,503
Ensembl chr11:22,338,381...22,379,503
JBrowse link
G SLC1A2 solute carrier family 1 member 2 decreases expression EXP thifluzamide results in decreased expression of SLC1A2 mRNA CTD PMID:33512557 NCBI chr11:35,251,205...35,420,058
Ensembl chr11:35,251,205...35,420,063
JBrowse link
G SLC1A4 solute carrier family 1 member 4 increases expression EXP thifluzamide results in increased expression of SLC1A4 mRNA CTD PMID:33512557 NCBI chr 2:64,988,479...65,023,865
Ensembl chr 2:64,988,477...65,023,865
JBrowse link
G SLC2A6 solute carrier family 2 member 6 decreases expression EXP thifluzamide results in decreased expression of SLC2A6 mRNA CTD PMID:33512557 NCBI chr 9:133,471,094...133,479,127
Ensembl chr 9:133,471,094...133,479,127
JBrowse link
G SLC38A1 solute carrier family 38 member 1 increases expression EXP thifluzamide results in increased expression of SLC38A1 mRNA CTD PMID:33512557 NCBI chr12:46,183,063...46,269,149
Ensembl chr12:46,183,063...46,270,017
JBrowse link
G SLC3A2 solute carrier family 3 member 2 increases expression EXP thifluzamide results in increased expression of SLC3A2 mRNA CTD PMID:33512557 NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
JBrowse link
G SLC6A3 solute carrier family 6 member 3 decreases expression EXP thifluzamide results in decreased expression of SLC6A3 mRNA CTD PMID:33512557 NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
JBrowse link
G SLC7A5 solute carrier family 7 member 5 increases expression EXP thifluzamide results in increased expression of SLC7A5 mRNA CTD PMID:33512557 NCBI chr16:87,830,022...87,869,507
Ensembl chr16:87,830,023...87,869,507
JBrowse link
G SLIT2 slit guidance ligand 2 decreases expression EXP thifluzamide results in decreased expression of SLIT2 mRNA CTD PMID:33512557 NCBI chr 4:20,251,905...20,620,561
Ensembl chr 4:20,251,905...20,620,561
JBrowse link
G SNAI2 snail family transcriptional repressor 2 increases expression EXP thifluzamide results in increased expression of SNAI2 mRNA CTD PMID:33512557 NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
JBrowse link
G SNHG8 small nucleolar RNA host gene 8 increases expression EXP thifluzamide results in increased expression of SNHG8 mRNA CTD PMID:33512557 NCBI chr 4:118,278,762...118,279,823
Ensembl chr 4:118,278,705...118,285,316
JBrowse link
G SPAG5 sperm associated antigen 5 increases expression EXP thifluzamide results in increased expression of SPAG5 mRNA CTD PMID:33512557 NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025
JBrowse link
G SPC25 SPC25 component of NDC80 kinetochore complex increases expression EXP thifluzamide results in increased expression of SPC25 mRNA CTD PMID:33512557 NCBI chr 2:168,865,045...168,890,443
Ensembl chr 2:168,834,132...168,913,371
JBrowse link
G SPDEF SAM pointed domain containing ETS transcription factor decreases expression EXP thifluzamide results in decreased expression of SPDEF mRNA CTD PMID:33512557 NCBI chr 6:34,537,800...34,556,329
Ensembl chr 6:34,537,802...34,556,333
JBrowse link
G SPRED2 sprouty related EVH1 domain containing 2 increases expression EXP thifluzamide results in increased expression of SPRED2 mRNA CTD PMID:33512557 NCBI chr 2:65,307,425...65,432,599
Ensembl chr 2:65,310,851...65,432,637
JBrowse link
G SRSF10 serine and arginine rich splicing factor 10 increases expression EXP thifluzamide results in increased expression of SRSF10 mRNA CTD PMID:33512557 NCBI chr 1:23,964,347...23,980,370
Ensembl chr 1:23,964,347...23,980,927
JBrowse link
G SST somatostatin decreases expression EXP thifluzamide results in decreased expression of SST mRNA CTD PMID:33512557 NCBI chr 3:187,668,912...187,670,394
Ensembl chr 3:187,668,912...187,670,394
JBrowse link
G SYTL1 synaptotagmin like 1 increases expression EXP thifluzamide results in increased expression of SYTL1 mRNA CTD PMID:33512557 NCBI chr 1:27,342,022...27,353,932
Ensembl chr 1:27,342,020...27,353,937
JBrowse link
G TAF9 TATA-box binding protein associated factor 9 increases expression EXP thifluzamide results in increased expression of TAF9 mRNA CTD PMID:33512557 NCBI chr 5:69,364,743...69,369,824
Ensembl chr 5:69,362,026...69,370,013
JBrowse link
G TCF4 transcription factor 4 decreases expression EXP thifluzamide results in decreased expression of TCF4 mRNA CTD PMID:33512557 NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787
JBrowse link
G TFDP1 transcription factor Dp-1 decreases expression EXP thifluzamide results in decreased expression of TFDP1 mRNA CTD PMID:33512557 NCBI chr13:113,584,688...113,641,473
Ensembl chr13:113,584,721...113,641,473
JBrowse link
G TGFB3 transforming growth factor beta 3 decreases expression EXP thifluzamide results in decreased expression of TGFB3 mRNA CTD PMID:33512557 NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
JBrowse link
G TMEM97 transmembrane protein 97 decreases expression EXP thifluzamide results in decreased expression of TMEM97 mRNA CTD PMID:33512557 NCBI chr17:28,319,041...28,328,685
Ensembl chr17:28,319,200...28,328,685
JBrowse link
G TNC tenascin C decreases expression EXP thifluzamide results in decreased expression of TNC mRNA CTD PMID:33512557 NCBI chr 9:115,019,575...115,118,244
Ensembl chr 9:115,019,575...115,118,257
JBrowse link
G TNFRSF10B TNF receptor superfamily member 10b increases expression EXP thifluzamide results in increased expression of TNFRSF10B mRNA CTD PMID:33512557 NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
JBrowse link
G TOP2A DNA topoisomerase II alpha increases expression EXP thifluzamide results in increased expression of TOP2A mRNA CTD PMID:33512557 NCBI chr17:40,388,525...40,417,902
Ensembl chr17:40,388,525...40,417,896
JBrowse link
G TPI1 triosephosphate isomerase 1 decreases expression EXP thifluzamide results in decreased expression of TPI1 mRNA CTD PMID:33512557 NCBI chr12:6,866,834...6,870,948
Ensembl chr12:6,867,119...6,870,948
JBrowse link
G TPX2 TPX2 microtubule nucleation factor increases expression EXP thifluzamide results in increased expression of TPX2 mRNA CTD PMID:33512557 NCBI chr20:31,739,248...31,801,802
Ensembl chr20:31,739,271...31,801,805
JBrowse link
G TRIB3 tribbles pseudokinase 3 increases expression EXP thifluzamide results in increased expression of TRIB3 mRNA CTD PMID:33512557 NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
JBrowse link
G TRIM13 tripartite motif containing 13 decreases expression EXP thifluzamide results in decreased expression of TRIM13 mRNA CTD PMID:33512557 NCBI chr13:49,997,042...50,018,467
Ensembl chr13:49,995,888...50,020,481
JBrowse link
G TRIM16L tripartite motif containing 16 like increases expression EXP thifluzamide results in increased expression of TRIM16L mRNA CTD PMID:33512557 NCBI chr17:18,697,998...18,736,112
Ensembl chr17:18,697,998...18,736,118
JBrowse link
G TSC22D3 TSC22 domain family member 3 increases expression EXP thifluzamide results in increased expression of TSC22D3 mRNA CTD PMID:33512557 NCBI chr  X:107,713,221...107,777,329
Ensembl chr  X:107,713,221...107,777,342
JBrowse link
G TTK TTK protein kinase increases expression EXP thifluzamide results in increased expression of TTK mRNA CTD PMID:33512557 NCBI chr 6:80,004,147...80,042,651
Ensembl chr 6:80,003,887...80,042,527
JBrowse link
G TUBB2A tubulin beta 2A class IIa decreases expression EXP thifluzamide results in decreased expression of TUBB2A mRNA CTD PMID:33512557 NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
JBrowse link
G TUBB2B tubulin beta 2B class IIb decreases expression EXP thifluzamide results in decreased expression of TUBB2B mRNA CTD PMID:33512557 NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
JBrowse link
G TUBB3 tubulin beta 3 class III decreases expression EXP thifluzamide results in decreased expression of TUBB3 mRNA CTD PMID:33512557 NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
JBrowse link
G TUT7 terminal uridylyl transferase 7 decreases expression EXP thifluzamide results in decreased expression of TUT7 mRNA CTD PMID:33512557 NCBI chr 9:86,287,733...86,354,497
Ensembl chr 9:86,287,733...86,354,454
JBrowse link
G TXNDC5 thioredoxin domain containing 5 increases expression EXP thifluzamide results in increased expression of TXNDC5 mRNA CTD PMID:33512557 NCBI chr 6:7,881,517...7,910,788
Ensembl chr 6:7,881,517...7,910,788
JBrowse link
G TXNIP thioredoxin interacting protein decreases expression EXP thifluzamide results in decreased expression of TXNIP mRNA CTD PMID:33512557 NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
JBrowse link
G TXNRD1 thioredoxin reductase 1 increases expression EXP thifluzamide results in increased expression of TXNRD1 mRNA CTD PMID:33512557 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
JBrowse link
G TXNRD2 thioredoxin reductase 2 increases expression EXP thifluzamide results in increased expression of TXNRD2 mRNA CTD PMID:33512557 NCBI chr22:19,875,522...19,941,818
Ensembl chr22:19,875,517...19,941,820
JBrowse link
G UBB ubiquitin B increases expression EXP thifluzamide results in increased expression of UBB mRNA CTD PMID:33512557 NCBI chr17:16,380,779...16,382,745
Ensembl chr17:16,380,798...16,382,745
JBrowse link
G UBE2C ubiquitin conjugating enzyme E2 C increases expression EXP thifluzamide results in increased expression of UBE2C mRNA CTD PMID:33512557 NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
JBrowse link
G UHRF1 ubiquitin like with PHD and ring finger domains 1 decreases expression EXP thifluzamide results in decreased expression of UHRF1 mRNA CTD PMID:33512557 NCBI chr19:4,903,080...4,962,154
Ensembl chr19:4,903,080...4,962,154
JBrowse link
G VEGFA vascular endothelial growth factor A increases expression EXP thifluzamide results in increased expression of VEGFA mRNA CTD PMID:33512557 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VEGFD vascular endothelial growth factor D decreases expression EXP thifluzamide results in decreased expression of VEGFD mRNA CTD PMID:33512557 NCBI chr  X:15,345,596...15,384,413
Ensembl chr  X:15,345,596...15,384,413
JBrowse link
G VIM vimentin increases expression EXP thifluzamide results in increased expression of VIM mRNA CTD PMID:33512557 NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
JBrowse link
G WARS1 tryptophanyl-tRNA synthetase 1 increases expression EXP thifluzamide results in increased expression of WARS1 mRNA CTD PMID:33512557 NCBI chr14:100,333,789...100,376,327
Ensembl chr14:100,333,790...100,376,805
JBrowse link
G WDTC1 WD and tetratricopeptide repeats 1 decreases expression EXP thifluzamide results in decreased expression of WDTC1 mRNA CTD PMID:33512557 NCBI chr 1:27,234,613...27,308,636
Ensembl chr 1:27,234,632...27,308,636
JBrowse link
G XBP1 X-box binding protein 1 increases expression EXP thifluzamide results in increased expression of XBP1 mRNA CTD PMID:33512557 NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
JBrowse link
G XIC X chromosome inactivation center increases expression EXP thifluzamide results in increased expression of XIC mRNA CTD PMID:33512557
G ZEB2 zinc finger E-box binding homeobox 2 decreases expression EXP thifluzamide results in decreased expression of ZEB2 mRNA CTD PMID:33512557 NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 25199
    role 25124
      biological role 25096
        biochemical role 24557
          enzyme inhibitor 21501
            EC 1.* (oxidoreductase) inhibitor 18637
              EC 1.3.* (oxidoreductase acting on donor CH-CH group) inhibitor 6903
                EC 1.3.5.* (oxidoreductase acting on CH-CH of donor with a quinone or related compound as acceptor) inhibitor 307
                  EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor + 305
                  EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor + 3
paths to the root